Insider filing · MPLT
James Woodruff Lillie
Chief Scientific Officer
profile →
MapLight Therapeutics, Inc.
MPLT · Healthcare · 32 filings in 24 months
ticker →
James Woodruff Lillie sold $277K of MapLight Therapeutics (MPLT)
Executed Aug 3, disclosed Aug 5, 1 day later.
Value, as filed
$277K
22,082 sh × $12.54
Executed
Aug 3
the trade date, as filed
Disclosed
Aug 5
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JLJames Woodruff Lillie (Chief Scientific Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $1.4M of MPLT (49,719 sh across 5 lots, as filed), executed May 4.
The name
MPLTHealthcare · MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by James Woodruff Lillie in MPLT
MPLTSALE
MapLight Therapeutics, Inc.
$513K13,928 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 9:45 PM ET MPLTSALE MapLight Therapeutics, Inc. $1.4M
49,719 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET